Back to results
TerminatedPhase 2

Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve

NCT02113553

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Istituto Clinico Humanitas

Rozzano, Milan, Italy

View on ClinicalTrials.gov
Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve — TrialFind